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Abstract
Background: Many chronic diseases, such as non-healing wounds are characterized by prolonged inflammation
and respond poorly to conventional treatment. Bacterial biofilms are a major impediment to wound healing.
Persistent infection of the skin allows the formation of complex bacterial communities termed biofilm. Bacteria
living in biofilms are phenotypically distinct from their planktonic counterparts and are orders of magnitude more
resistant to antibiotics, host immune response, and environmental stress. Staphylococcus aureus is prevalent in
cutaneous infections such as chronic wounds and is an important human pathogen.
Results: The impact of S. aureus soluble products in biofilm-conditioned medium (BCM) or in planktonic-
conditioned medium (PCM) on human keratinocytes was investigated. Proteomic analysis of BCM and PCM
revealed differential protein compositions with PCM containing several enzymes involved in glycolysis. Global gene
expression of keratinocytes exposed to biofilm and planktonic S. aureus was analyzed after four hours of exposure.
Gene ontology terms associated with responses to bacteria, inflammation, apoptosis, chemotaxis, and signal
transduction were enriched in BCM treated keratinocytes. Several transcripts encoding cytokines were also
upregulated by BCM after four hours. ELISA analysis of cytokines confirmed microarray results at four hours and
revealed that after 24 hours of exposure, S. aureus biofilm induced sustained low level cytokine production
compared to near exponential increases of cytokines in planktonic treated keratinocytes. The reduction in cytokines
produced by keratinocytes exposed to biofilm was accompanied by suppressed phosphorylation of MAPKs.
Chemical inhibition of MAPKs did not drastically reduce cytokine production in BCM-treated keratinocytes
suggesting that the majority of cytokine production is mediated through MAPK-independent mechanisms.
Conclusions: Collectively the results indicate that S. aureus biofilms induce a distinct inflammatory response
compared to their planktonic counterparts. The differential gene expression and production of inflammatory
cytokines by biofilm and planktonic cultures in keratinocytes could have implications for the formation and
persistence of chronic wounds. The formation of a biofilm should be considered in any study investigating host
response to bacteria.
Background
In many environments bacteria exist as a complex, multi-
species surface-associated community termed biofilm.
Bacteria within these communities secrete an extracellu-
lar polymer matrix, form complex structures, and are
phenotypically distinct from their planktonic counter-
parts [1,2], and are orders of magnitude more resistant to
antibiotics and biocides than planktonic bacteria [3].
Furthermore, bacterial genes involved in biofilm forma-
tion are controlled by regulatory systems that also con-
trol the expression of virulence factors [4,5].
Bacterial biofilms are a major barrier to healing in
chronic wounds. In patients with underlying disease (i.e.
diabetes, pulmonary disease), wounded epithelium offers
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to susceptibility to contamination, availability of nutri-
ents, and abundant surface area for attachment.
Chronic-wound biofilms are not cleared by the host’s
immune system and are resistant to traditional treat-
ment strategies such as antibiotics [6]. Cutaneous
wounds progress through three highly regulated phases
of wound repair: inflammation, epithelialization, and tis-
sue remodeling. Chronic wounds display abnormal pro-
gression through these phases including prolonged
inflammation and failure to re-epithelialize. Currently,
removal of the biofilm by frequent debridement is one
of the most clinically effective treatments applied to
chronic wounds [7]. A recent study showed that biofilms
were prevalent in chronic wounds and rare in acute
wounds [8], but the role biofilms play in preventing
wound healing and mechanisms involved have yet to be
determined.
S. aureus is an important human pathogen associated
with numerous skin diseases including chronic-wound
infections. S. aureus p r o d u c e saw i d er a n g eo fv i r u l e n c e
factors including hemotoxins, pore forming toxins, and
superantigens (e.g. toxic shock syndrome toxin-1, Sta-
phylococcal enterotoxin). The impact of biofilm forma-
tion on S. aureus virulence is controversial. In one study,
virulence factor gene expression in S. aureus cells within
a biofilm was shown to be downregulated when com-
pared to planktonic S. aureus cultures [2]. Another study
showed that biofilm formation had no effect on the viru-
lence of S. aureus [9], while several studies highlight the
necessity of regulatory elements associated with biofilm
formation on the regulation of virulence [10,11].
Human keratinocytes (HKs) are the most abundant
cell type in the epidermis and are essential for wound
healing. HKs are constantly exposed to bacterial stimuli
and function in innate immunity through the formation
of a physical barrier to the external environment and
the recognition of conserved pathogen associated mole-
cular patterns (PAMPs). Examples of PAMPs include
the bacterial cell wall components peptidoglycan and
lipoteichoic acid, bacterial DNA, flagella, and other con-
served structures [12]. PAMPs are recognized by cell
surface receptors called toll like receptors (TLRs) which
are found on a variety of cell types including profes-
sional immune cells, endothelial cells, and cells of the
epidermis. HKs express functional TLRs making them
the first line of defense against bacteria in the skin [13].
HK activation induced by TLRs in response to bacterial
stimuli is mediated in part by mitogen activated protein
kinase (MAPK; specifically JNK, p38, and ERK) cascades
resulting in the production of inflammatory cytokines
[14-16]. MAPKs are major components regulating the
pathology of chronic inflammation, diabetes mellitus,
and other chronic diseases [17,18]. The highly
orchestrated production of inflammatory cytokines by
HKs is an important initial step in a normal immune
response. Derangement of cytokine production by bac-
terial infection can lead to chronic inflammatory condi-
tions [19].
In this study, we investigated the transcriptional
response of HKs exposed to S. aureus biofilm condi-
tioned medium (BCM) and planktonic conditioned med-
ium (PCM) to reveal genes associated with pathogenesis.
We correlated microarray data with data from enzyme-
linked immunoassays (ELISA) and enzyme inhibition
assays, to delineate a biofilm specific response associated
with inflammation in HKs and formulate a hypothesis
for biofilm-induced pathogenesis in chronic wounds.
Results
Proteomic analysis of BCM and PCM
A preliminary proteomic analysis of BCM and PCM
revealed differential protein compositions. BCM con-
tained slightly more total protein than PCM and analysis
by 1D gel electrophoresis revealed BCM contained a
more complex banding pattern than PCM (Figure 1).
Additionally, smearing was consistently observed in the
BCM possibly indicating the presence of a bacterial pro-
tease. Protein identification of selected bands by mass
spectrometry is listed in Table 1. PCM was found to con-
tain several enzymes involved in glycolysis while BCM
contained proteins relating to translation in addition to
proteins which were not identified by a Mascot search.
S. aureus BCM upregulates genes associated with
inflammation and apoptosis in human keratinocytes
The transcriptional response of HKs exposed to S. aur-
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Figure 1 1D SDS - PAGE and Total Protein Concentration in
BCM and PCM. The total protein concentration in BCM and PCM
did not differ drastically (A), but several differences in the
extracellular proteome of planktonic and biofilm cultures of S.
aureus were revealed by 1D SDS-PAGE (B). The presence of a smear
and low molecular weight peptides in the BCM indicates the
presence of a bacterial protease. Bands in (B) marked with an arrow
were excised and analyzed by HPLC-MS/MS (Table 1).
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Page 2 of 13to BCM and PCM for four hours prior to microarray
analysis. Our previous results indicated that after four
hours of exposure to BCM, HKs undergo cytoskeletal
rearrangements including the formation of filopodial
structures and rounding of the cell body, but have not
started late-stage apoptotic programs [20].
Transcriptional analysis revealed that BCM upregu-
lated 65 transcripts and downregulated 247 transcripts
at least 1.5 fold (p < 0.01) compared to PCM (Addi-
tional file 1). Some of the most highly upregulated tran-
scripts by BCM included (i) activated protein-1 (AP-1)
family members (fos, atf, jun), (ii) egr1 stress response
Table 1 Proteins identified by HPLC-MS/MS
Band
#
Sample NCBI
Accession
Name Function
1 BCM gi15924466 30S ribosomal protein S1 [Staphylococcus aureus subsp. aureus Mu50] translation
1 BCM gi227557405 elongation factor G [Staphylococcus aureus subsp. aureus MN8] translation
2 BCM gi15923949 glycerophosphoryl diester hosphodiesterase [Staphylococcus aureus subsp. aureus
Mu50]
glycerophospholipid
metabolism
3 BCM gi15924653 valyl-tRNA synthetase [Staphylococcus aureus subsp. aureus Mu50] translation
4 BCM gi258423763 isoleucyl-tRNA synthetase Staphylococcus aureus A9635] translation
5 BCM gi2506027 N-acetyl-glucosaminidase [Staphylococcus aureus] exoglycosidase
6 BCM gi15924060 amidophosphoribosyltransferase Staphylococcus aureus subsp. aureus Mu50] purine nucleotide
biosynthesis
7 BCM gi128852 Staphylococcal nuclease nuclease
8 BCM No
significant
hits
NA NA
9 BCM gi258424814 catalase [Staphylococcus aureus A9635] antioxidant/oxidative
stress
9 BCM gi21282950 catalase [Staphylococcus aureus subsp. aureus MW2] antioxidant/oxidative
stress
10 BCM No
significant
hits
NA NA
11 BCM No
significant
hits
NA NA
12 BCM&PCM gi15925406 phosphoglycerate mutase [Staphylococcus aureus subsp. aureus Mu50] glycolysis
12 BCM&PCM gi282917765 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase [Staphylococcus aureus
subsp. aureus D139]
glycolysis
12 BCM&PCM gi|15927092 6-phosphogluconate dehydrogenase [Staphylococcus aureus subsp. aureus N315] Pentose phosphate
bifunctional 3-deoxy-7-hosphoheptulonate
12 BCM&PCM gi15924727 synthase/chorismate mutase [Staphylococcus aureus subsp. shikimate pathway
aureus Mu50]
12 BCM&PCM gi15923310 glycerol ester hydrolase [Staphylococcus aureus subsp. aureus Mu50] lipase
13 BCM&PCM gi15924543 superoxide dismutase [Staphylococcus aureus subsp. aureus Mu50] antioxidant/oxidative
stress
14 BCM&PCM gi15923346 5-methyltetrahydropteroyltriglutamate–homocysteine S-methyltransferase
[Staphylococcus aureus subsp. aureus Mu50]
methionine metabolism
14 BCM&PCM gi293501167 aconitate hydratase 1 [Staphylococcus aureus subsp. aureus 58-424] TCA
15 PCM gi15925596 fructose-1,6-bisphosphate aldolase [Staphylococcus aureus subsp. aureus Mu50] glycolysis
16 PCM gi15923621 lipoprotein [Staphylococcus aureus subsp. aureus Mu50] cell wall component
16 PCM gi15925115 fructose-bisphosphate aldolase [Staphylococcus aureus subsp. aureus Mu50] glycolysis
17 PCM gi289550260 fructose-bisphosphate aldolase class II [Staphylococcus lugdunensis HKU09-01] glycolysis
17 PCM gi283470068 phosphoglycerate kinase [Staphylococcus aureus subsp. aureus ST398] glycolysis
18 PCM gi15923952 glucose-6-phosphate isomerase [Staphylococcus aureus subsp. aureus Mu50] glycolysis
18 PCM gi15923762 glyceraldehyde-3-phosphate dehydrogenase [Staphylococcus aureus subsp. aureus
Mu50]
glycolysis
18 PCM gi151221290 ornithine carbamoyltransferase [Staphylococcus aureus subsp. aureus str. Newman] urea cycle
Proteins identified by HPLC-MS/MS analysis. Band numbers represent excised bands from 1D-SDS PAGE analysis of BCM and PCM (Figure 1).
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Page 3 of 13transcription factor, and (iii) cytokines. The calcium-
binding protein S100P, which has been described as
diagnostic for chronic inflammation [21], was also found
to be upregulated 2.2 fold by BCM compared to PCM.
Nuclear factor kappa B (NFkB) negative regulators
TNFAIP3 (A20) and NFkBIA were also upregulated in
BCM-treated HKs, indicating active regulation of this
important inflammatory pathway.
An enrichment analysis was conducted using The
Database for Annotation, Visualization and Integrated
Discovery (DAVID) functional annotation clustering
tool to identify over-represented (p < 0.05; Benjamini
Hochberg correction for multiple testing) gene ontology
terms. Seven functional annotation clusters with enrich-
ment scores greater than 1.5 were identified in upregu-
lated transcripts while five functional annotation clusters
were identified in downregulated genes. Over-repre-
sented clusters in the upregulated transcript list con-
tained terms relating to response to bacteria and
external stimuli, apoptosis, immune response and
inflammation, and signal transduction (Figure 2). Over-
represented clusters in the downregulated transcript list
contained terms associated with chromatin modification,
transcription, and metabolism.
S. aureus BCM induces apoptosis in HKs
Enrichment analysis of microarray data indicated genes
relating to apoptosis were over-represented in BCM
treated HKs. Apoptosis was confirmed using a TUNEL
assay. A significant percentage of BCM treated HKs
were undergoing apoptosis at four and 24 hours while
the percentage of apoptotic PCM treated HKs was not
significantly different from control cells (Figure 3A).
Additionally, a significant decrease in adherent cell
numbers was observed after 24 hours of exposure to
BCM which was not observed in PCM treated HKs
(Figure 3B).
S. aureus PCM induces higher levels of cytokine
production relative to BCM in human keratinocytes
Several of the most significantly upregulated genes
induced by BCM encoded cytokines. Therefore, we
tested the effects of BCM and PCM on cytokine produc-
tion in HKs. ELISA was used to confirm the production
of cytokines IL-1b,I L - 6 ,T N F - a, GM-CSF and chemo-
kines CXCL-8 and CXCL-1 at the protein level. ELISA
cytokine measurements at 4 and 24 hours were reported
as picogram of cytokine per 100,000 adherent, non-
apoptotic cells to account for the observed BCM-
induced decrease in cell numbers and induction of
apoptosis (Figure 4). ELISA data revealed that after four
hours of treatment, BCM-treated HKs produced more
cytokines, in agreement with the microarray data. After
24 hours of exposure to BCM, cytokines secreted by
HKs leveled off, and in some cases, even decreased.
After 24 hours, PCM-treated HKs produced roughly an
order of magnitude more of each cytokine, with the
exception of TNF-a, which was produced in greater
quantities in BCM-treated HKs after 24 hours.
S.aureus BCM suppresses JNK and p38 phosphorylation
and induces MAPK independent cytokine production in
human keratinocytes
Functional enrichment of BCM induced genes revealed
genes involved in MAPK cascades were over-repre-
sented in BCM treated HKs. To determine if the
MAPKs JNK, p38, and ERK were differentially activated
in HKs by BCM or PCM, levels of phosphorylated and
total JNK, p38, and ERK were measured using cell-based
ELISAs (Figure 5). Levels of phosphorylated JNK and
p38 decreased after exposure to BCM. Exposure of HKs
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Figure 2 Functional clustering of BCM induced genes.
Functional terms significantly associated (p < 0.05, Benjamini
correction for multiple testing) with BCM induced genes relative to
PCM induced genes. Functional annotation clusters with an
enrichment score greater than 1.5 were considered significant. (A)
Analysis of significantly upregulated genes (fold change ≥1.5)
revealed functional annotation clusters associated with response to
bacteria and external stimuli, apoptosis, immune response and
inflammation, and signal transduction. (B) Analysis of significantly
downregulated genes (fold change ≤1.5) revealed functional
annotation clusters associated with chromatin modification,
transcription, and metabolism.
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Page 4 of 13to PCM resulted in increased phosphorylation of JNK
and to a lesser extent, p38. Phosphorylation of ERK was
increased in BCM treated cells and unchanged in PCM
treated cells. MAPK phosphorylation data were not nor-
malized to adherent cell numbers as ratios of phos-
phorylated MAPK/total MAPK were measured only in
adherent cells, accounting for reduced cell numbers.
Apoptotic adherent cells were not accounted for in
these data due to several reports of MAPK activation in
apoptotic keratinocytes [22,23]. These data indicate that
S. aureus BCM suppresses JNK and p38 phosphorylation
levels below those of control cells which may lead to
reduced cytokine levels.
To investigate the effect of MAPK signaling on cyto-
kine production in BCM and PCM-treated HKs, the
MAPK family members JNK, p38, and ERK were inhib-
ited using the inhibitors SP600125, SB203580, and
U0126, respectively. Levels of GM-CSF were not ana-
lyzed in these experiments due to nearly undetectable
levels at all time points except after 24 hours of expo-
sure to PCM (Figure 4). Inhibition of JNK, p38, and
ERK led to significant (p < 0.05) decreases in cytokine
and chemokine production in PCM-treated HKs relative
to BCM-treated HKs with the exception of IL-6 produc-
tion in ERK-inhibited HKs (Figure 6). The data demon-
strate that the majority of cytokines in BCM-treated
HKs are produced through MAPK-independent
mechanisms.
We have previously described characteristic morphol-
ogy changes in BCM treated HKs [20]. The effects of
MAPK inhibitors on BCM induced cell morphology
were investigated here. Inhibition of JNK, p38, or ERK
did not prevent the biofilm-induced formation of filopo-
dial structures in HKs (data not shown). Overall, this
indicates that cytoskeletal rearrangements induced by
BCM act through MAPK-independent mechanisms.
Discussion
S. aureus biofilm and planktonic-conditioned medium
induced distinct responses in HKs in vitro.T h ea d v e r s e
effects of planktonic bacterial cultures on mammalian
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Figure 4 Cytokine production in adherent, non - apoptotic HKs
exposed to BCM or PCM. BCM induces more cytokines per
adherent, non-apoptotic cell after four hours while PCM induces
more cytokines per adherent, non-apoptotic cell after 24 hours.
Cytokine levels in HKs after 4 (A) and 24 hours (B) of exposure to
PCM, BCM, or Control. Data normalized to pg protein/100,000,
TUNEL negative, adherent cells. Results represented as mean ± SD,
n = 3, *p < 0.05, **p < 0.01.
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Figure 5 MAPK phosphorylation in HKs exposed to BCM or
PCM. MAPK phosphorylation in HKs exposed to PCM or BCM for 4
or 24 hours. p38 (A) and JNK (B) phosphorylation levels were
decreased in BCM treated HKs after 4 and 24 hours of exposure to
BCM while PCM induced p38 and JNK phosphorylation after 24
hours. ERK phosphorylation (C) was unchanged in PCM treated HKs
and increased in BCM treated HKs. Results represented as mean ±
SD, n = 6, *p < 0.05, **p < 0.01 relative to control cells.
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Figure 3 BCM induces apoptosis and cell detachment in HKs.
(A) Percentage of HKs staining positive for TUNEL. BCM induces
significant levels of apoptosis in HKs after 4 and 24 hours of
exposure while PCM does not. TUNEL data represents positive
TUNEL cell counts over total cell counts. (B) Total cell counts
obtained from propidium iodide stained HKs. After 24 hours of
exposure to BCM, roughly half of the BCM treated HKs were still
adhering to the culture well. Results represented as mean ± SD, n =
4, ** p < 0.01.
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Page 5 of 13cells have been well documented in vitro. Bacterial cells
grown in broth cultures have long been assumed to
retain the same pathogenic properties as bacteria in nat-
ural settings. While important discoveries have been
realized based on planktonic studies, data presented
here provide evidence that bacterial biofilms differen-
tially induce pathogenesis in cultured HKs.
Host-pathogen interactions were investigated between
a clinical isolate of S. aureus and HKs. A preliminary
analysis of the extracellular proteome of S. aureus bio-
film and planktonic cultures was performed by 1D gel
electrophoresis and mass spectrometry. Several differ-
ences were observed in the 1D gel band patterns of
BCM and PCM (Figure 1). The total protein concentra-
tions of BCM and PCM were found to be similar, but
BCM clearly contained more features. Smearing of BCM
in 1D gels was observed indicating possible bacterial
protease activity, although such a protease was not iden-
tified by mass spectrometry (Table 1). S. aureus secretes
a variety of proteases which are important in pathogen-
esis [24]. The presence of such a protease could explain
some of the observed effects in HKs after treatment
with BCM or PCM.
Several 1D gel bands visible in PCM and not BCM
contained glycolytic enzymes (Figure 1, Table 1). The
presence of intracellular glycolytic enzymes in the
extracellular proteome of S. aureus may be due to cell
lysis, but cell wall associated glycolytic enzymes have
been described for numerous pathogens, including S.
aureus [25,26]. Links between central metabolism and
virulence in S. aureus have been described. In S. aureus,
when carbon sources are plentiful, glycolysis is active
while the tricarboxcylic acid (TCA) cycle is largely
repressed [27]. The TCA cycle has been described as a
signal transduction pathway capable of regulating toxin
production [28], adhesion synthesis and biofilm forma-
tion [29,30], and antibiotic susceptibility [31]. Addition-
ally, S. aureus deletion mutants for the glycolytic
enzymes gapA and gapB have been shown to have atte-
nuated pathogenic capabilities [32]. The presence of sev-
eral glycolytic enzymes in PCM and not in BCM
supports the notion that central metabolic processes are
in different states in planktonic and biofilm cultures and
that those different metabolic states likely have a large
impact on the observed pathogenic effects on HKs
described here.
Functional annotation clustering of upregulated tran-
scripts revealed over-represented annotation clusters
associated with response to bacteria, regulation of tran-
scription, inflammation, and signal transduction (Figure
2). The gene ontology term “response to glucocorticoid
stimulus” was interesting as glucocorticoids are anti-
inflammatory hormones. Genes involved in cyclic ade-
nosine monophosphate (cAMP) signaling were also
interesting since cAMP is involved in several fundamen-
tal cellular processes and may be partially responsible
for the observed effects induced by BCM. Functional
annotation clustering of downregulated transcripts
revealed over-represented annotation clusters associated
with transcription and metabolism. The downregulation
of genes associated with these processes may indicate a
general cessation in BCM treated cells.
Transcriptional responses of HKs to BCM revealed the
upregulation of pro-inflammatory genes, including tran-
scripts for pro-inflammatory transcription factors, cyto-
kines, and apoptosis related genes. Among these were
members of the AP-1 family of transcription factors and
regulators of the NFkB pro-inflammatory transcription
factor, TNFAIP3 (A20) and NFkBIA. Expression of these
genes indicated active regulation of the NFkB pathway.
NFkB regulates the expression of many genes involved in
immune and inflammatory responses (i.e. cytokine and
chemokine genes) and often acts in synergy with AP-1 to
mediate inflammatory responses [33,34]. NFkB and AP-1
are activated by pro-inflammatory cytokines such as TNF-
a and IL-1b which act through MAPK-dependent signal
cascades resulting in the production of additional cyto-
kines [35-38]. The transcription factor egr1,w h i c hw a s
highly upregulated in BCM treated HKs, is also involved
in the regulation of pathophysiologically important genes
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Figure 6 MAPK inhibition and cytokine production in BCM and
PCM treated HKs. Cytokine production in MAPK inhibited HKs after
4 hours of exposure to PCM or BCM relative to non-inhibited
control (BCM or PCM supplemented with DMSO). In general, MAPK
inhibition resulted in a greater reduction of cytokine production in
PCM treated HKs compared to BCM treated HKs. Results represented
as mean ± SD, n = 3, *p < 0.05, **p < 0.01.
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Page 6 of 13relating to inflammation, apoptosis, and differentiation
[39-41]. The upregulation of these early response tran-
scription factors indicates that four hours of treatment
with BCM induces a swift inflammatory response in HKs
relative to PCM.
We previously investigated BCM induced apoptosis
and HK migration in a scratch wound model [20]. In
agreement with that study, S. aureus BCM induced apop-
tosis in HKs while PCM did not induce a significant
amount of apoptosis. BCM mediated induction of apop-
tosis is discussed in detail in [20]. This striking dissimi-
larity between PCM and BCM would undoubtedly have
substantial impacts on several aspects of wound healing.
Cytokine production induced by PCM and BCM were
normalized to adherent non-apoptotic HKs.
ELISA analysis of cytokine production in HKs revealed
that after four hours, BCM induced the production of
more cytokines relative to PCM treated HKs. However,
after 24 hours, BCM induced cytokine levels were weaker
relative to cytokine production induced by PCM. Even
though cytokine levels were normalized to non-apoptotic
cells, it is important to note that early stage apoptosis
may contribute to a general reduction in protein expres-
sion contributing to reduced cytokine levels. However, a
reduction in MAPK phosphorylation indicates an alterna-
tive mechanism to early stage apoptosis for cytokine
reduction.
Phosphorylation of the MAPKs JNK and p38 were
found to be reduced by BCM while ERK was not. Inhibi-
tion of MAPK pathways revealed that MAPK signaling
was responsible for a larger percentage of cytokine pro-
duction in PCM treated HKs compared to BCM treated
HKs. Even though there were strong differences in cyto-
kine production between BCM and PCM treated cells
after four hours, the representation of the inhibitor data
as a percent of the vehicle control helps to reveal to what
extent MAPKs are involved in cytokine production.
SB203580, U0126, and SP600125 are widely used inhibi-
tors of MAPKs. SB203580 and U0126 show a high degree
of specificity towards p38 and ERK while the specificity
of SP600125 towards JNK has recently been re-examined
[42]. SP600125 was found to inhibit a wider range of
kinases than initially thought. Given our goal to deter-
mine a generalized relationship between MAPK signaling
and cytokine production, the reduced specificity of the
JNK inhibitor SP600125 was tolerable. A specific role for
p38, ERK, and JNK in S. aureus biofilm mediated host
responses remains to be elucidated.
Several studies have investigated the inflammatory
effects of planktonic bacterial supernatants on mamma-
lian cells [43-52]. Genes upregulated by PCM were in
agreement with the upregulation of pro-inflammatory
genes in epithelial cells exposed to planktonic S. aureus
supernatant [47]. Similar cytokine gene expression
patterns were observed in human vaginal epithelial cells
when exposed to late exponential phase S. aureus cul-
tures [48]. Mid-logarithmic-phase cultures of S. aureus
planktonic-conditioned medium induced IL-6, CXCL-8,
and TNF-a in human-corneal-epithelial cells [44]. Dif-
ferent species of dental bacteria were found to induce
various levels of the cytokines IL-1b, IL-6, and CXCL-8
after 4 or 24 hours of challenge in human gingival
epithelial cells [52]; the ability of bacteria to induce
cytokine production was correlated to the virulence of
the strains tested.
Much less is known about the impacts of biofilm on
mammalian cell cultures. S. aureus BCM initially induced
higher levels of cytokines in HKs after four hours of
exposure followed by reduced levels of cytokine produc-
tion after 24 hours of exposure relative to PCM. The
exception was TNF-a, which was found to be produced
at higher levels in BCM treated HKs relative to PCM
treated HKs. TNF-a is a cytokine capable of inducing
apoptosis in many cell types including keratinocytes [53]
and may be partially responsible for the observed
increase in apoptotic HKs after exposure to BCM. In one
in vitro host-pathogen model incorporating dental bio-
films and human gingival epithelial cells, the cytokines
IL-1b, IL-6 and CXCL-8 were degraded by the biofilm
after four hours [54]. In that study, direct contact with
the biofilm was required for biofilm mediated degrada-
tion of cytokines as filtered biofilm supernatant similar to
BCM did not induce the degradation of cytokines. Our
results showed that direct contact with the biofilm was
not necessary for the observed decreases in cytokine pro-
duction after 24 hours of exposure. A recent study inves-
tigating the effects of S. aureus biofilm infection in a
mouse model found adaptive immune responses were
regulated through cytokine production as the biofilm
matured [55]. In that study, the production of key cyto-
kines at certain times during the infection was hypothe-
sized to manipulate the host’s adaptive immune response
resulting in localized tissue damage allowing S. aureus to
establish a mature biofilm and mount a successful
infection.
The patterns of cytokine and chemokine production
from HKs exposed to either PCM or BCM are analogous
to the patterns of cytokines produced during sepsis and
chronic inflammatory diseases, respectively. Sepsis is
characterized by release of massive amounts of cytokines
and is analogous to the effects of PCM on cytokine pro-
d u c t i o ni nH K s .C h r o n i ci n f l a m m a t i o n ,o nt h eo t h e r
hand, is similar to the effects of BCM where local inflam-
mation is induced, but a runaway, self-inducing inflam-
matory response is not produced.
Three sub-types of MAPKs have been identified in
mammals, ERK, JNK, and p38. JNK and p38 activation
in HKs by PCM agree with other reports of JNK and
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bacterial cultures similar to the planktonic cultures
described in this research [44,56-60]. Suppression of
JNK and p38 phosphorylation in BCM-treated HKs
below that of control and PCM-treated HKs occurred
after 4 hours. Transcriptional analysis of BCM-treated
HKs revealed the upregulation of dual specificity MAPK
negative regulators, which may be responsible for the
de-phosphorylation of JNK and p38 (Additional file 1).
ERK is involved in the regulation of differentiation,
apoptosis, and motility [61]. The activation of ERK may
be associated with the regulation of these processes in
HKs treated with BCM.
Chemical inhibition of MAPKs confirmed that PCM
treatment induced more MAPK-dependent cytokine
production than BCM in HKs after 4 hours of stimula-
tion. The relative ineffectiveness of the MAPK inhibitors
on BCM mediated cytokine production in addition to
the reduced phosphorylation status of JNK and p38 sug-
gests that BCM induces cytokine production through
MAPK independent signaling mechanisms and the pro-
duction of different factors by S. aureus biofilm com-
pared to planktonic cultures.
The suppression of MAPK signaling by BCM could
impact other wound-related activities involving MAPK
cascades in HKs including HK differentiation [62],
secretion of antimicrobial peptides [63], response to
mechanical stress [64], and response to osmotic stress
[65]. Suppression of MAPK signal transduction in HKs
would be detrimental to all phases of wound healing,
possibly contributing to the formation and/or persis-
tence of chronic wounds. The observed upregulation of
pro-inflammatory transcription factors at four hours
may be an attempt by the cell to compensate for
reduced MAPK signaling. The consequence of the over-
production of pro-inflammatory transcription factors
could be the cause for the greater production of cyto-
kines in BCM-treated HKs at four hours. Several tran-
scription factors are differentially regulated in BCM
treated HKs. Certain transcription factors induce or
inhibit AP-1. One such transcription factor is A20
which is known to activate AP-1 and inhibit activation
of JNK [66]. A20 was upregulated 3.09 fold in BCM
treated HKs relative to PCM treated cells (Additional
file 1). It is possible that other MAPK independent path-
ways are activated or inhibited by BCM mediated
MAPK inactivation resulting in A20 expression, leading
to the initial increase of AP-1 family transcription
factors.
Guggenheim et al. found that cytokines were degraded
by direct contact with an in vitro dental biofilm [54].
The smearing of BCM proteins on 1D gels indicates the
possible presence of a S. aureus protease that may be
responsible for the degradation of excreted cytokines.
However, the suppression of MAPK phosphorylation
and MAPK independent production of cytokines in
BCM treated HKs suggests that cytokine production is
at least partially limited through this important signaling
pathway. MAPK suppression in various mammalian cell
types by bacterial toxins has been observed. Bacillus
anthracis secretes lethal toxin, which cleaves most iso-
forms of MAPKs, reducing pro-inflammatory cytokine
secretion from immune cells [67]. Shigella flexneri, Yer-
sinia spp., and Salmonella spp. deliver toxins which
inhibit MAPK signal transduction through a type III
secretion mechanism resulting in the repression of
genes such as TNF-a, IL-6, and CXCL-8 [68,69]. To our
knowledge, a toxin has not been identified in S. aureus
that inhibits MAPK signaling, but it is tempting to spec-
ulate that such a toxin exists and is responsible for the
observed suppression of p38 and JNK phosphorylation.
The results presented here provide the basis to charac-
terize the response of HKs to BCM and allow the for-
mulation and testing of hypotheses as to specific
components in BCM that cause the observed HK
response. Metabolomic and proteomic characterization
of BCM are beyond the scope of the present work, but
it is relevant to mention that preliminary MS and NMR-
based metabolomics analysis revealed numerous meta-
bolites specific to S. aureus BCM (Our unpublished
observations).
A hypothetical mechanism of pathogenesis induced by
S. aureus infection as related to this work is presented
here. The initial infection of wounded tissue is assumed
to be primarily by planktonic S. aureus. That infection
could result in a normal inflammatory response where
the invading bacteria are destroyed and the tissue pro-
gresses through a normal healing response. If the host
were immune-compromised, had an underlying disease
(i.e. diabetes, pulmonary disease, or other inflammatory
diseases), or conditions were favorable for the pathogen,
S. aureus could successfully evade the immune system.
If S. aureus were successful in evading the host’s
immune response, the resulting infection could continue
to spread, reach the bloodstream and induce sepsis,
resulting in death (i.e. a planktonic S. aureus infection).
Alternatively, S. aureus could revert to a biofilm growth
phase where HK apoptosis and cytoskeletal rearrange-
ments would inhibit the re-epithelialization of the
w o u n d[ 2 0 ]a n dad e r a n g e di n f l a m m a t o r yr e s p o n s e
could establish a localized, persistent infection.
Conclusions
These data provide insights into mechanisms of patho-
genesis in biofilm-based chronic-wound infections. Pro-
cesses relating to epithelialization such as the disruption
of cytoskeletal components and induction of apoptosis
are induced by BCM in HKs. Suppression of MAPK
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production in BCM treated HKs could help to explain
the local, chronic inflammation observed in biofilm-
infected skin. Analysis of the extracellular proteome of S.
aureus suggested that planktonic and biofilm cultures
were in different metabolic states which may impact
pathogenesis in HKs. Collectively, the results help explain
the formation and persistence of chronic wounds. Addi-
tionally, the differences in pathogenesis between bacterial
biofilm and planktonic cultures detailed here highlight
the importance of considering biofilm formation in any
model of disease.
Methods
Cell Culture
Human foreskin keratinocytes (HFKs) and the sponta-
neously immortalized human HaCaT keratinocyte cell
line were used. HaCaT keratinocytes are a widely used
keratinocyte line which displays similar responses to
TLR ligands as primary keratinocytes and is suitable for
studies investigating innate immunity [14]. Additionally,
HaCaT keratinocytes undergo the same BCM induced
morphology changes, induction of apoptosis, and
increases in intracellular calcium as HFKs (this study
and our unpublished observations).
HFKs were cultured from newborn foreskin and pas-
saged in serum free medium using methods previously
described [70]. Cells were maintained in EpiLife
® kerati-
nocyte growth medium (Cascade Biologics, Portland,
OR) supplemented with human keratinocyte growth
supplement (HKGS; Cascade Biologics, Portland, OR).
Experiments were conducted with cell passages 4-10,
using EpiLife
® medium supplemented with HKGS (EPI).
HaCaT keratinocytes were maintained under identical
conditions. All cultures were kept in a humidified 5%
CO2 incubator at 37°C.
S. aureus Biofilm Culture Conditions and Preparation of
BCM
Tissue culture inserts (35 mm diameter, 0.2 μmp o r e
size, Nalge Nunc International, Rochester, NY) were
placed into six well plates with 2.1 ml of EPI in each
well. An initial overnight culture of a clinical isolate of
S. aureus (Southwest Regional Wound Care isolate #
10943, Lubbock, TX) was diluted in EPI to an optical
density of 0.05 at 600 nm. Seven 10 μld r o p so ft h e
diluted overnight culture were placed onto individual
culture inserts and biofilms were allowed to develop and
mature for 72 hours. Every 24 hours for four days there-
after, the growth medium was collected, filter sterilized,
pH adjusted to 7.2, and replaced with fresh EPI. The
collected medium is referred to as BCM. S. aureus BCM
was pooled to provide sufficient quantities of material to
work with and to help eliminate day to day variations
that might occur in the biofilm cultures.
Planktonic S. aureus Culture Conditions and Preparation
of PCM
Planktonic S. aureus cultures were grown under condi-
tions designed to produce similar cell densities and phy-
siology (i.e. stationary phase growth) as the biofilm
cultures. To obtain such a culture, mature three day old
biofilms grown on tissue culture inserts were re-sus-
pended into the same volume of EPI growth medium in
which biofilm cultures were maintained and cultured at
37°C with constant agitation. This method effectively
reverted S. aureus cells from biofilm growth back to
planktonic growth. Planktonic bacteria were removed
from solution by centrifugation. The supernatant was
collected, filter sterilized, and pH adjusted to 7.2. The
bacterial pellet was resuspended in EPI and cultured at
37°C with constant agitation for an additional 24 hours.
This process was repeated every 24 hours for four days
and the conditioned medium pooled to provide suffi-
cient material to work with and to help eliminate day to
day variations that might occur in overnight planktonic
cultures. The pooled, sterilized supernatant is referred
to as PCM. Both planktonic and re-suspended biofilm
cultures of S. aureus contained similar population densi-
ties based on optical density (600 nm) readings at 4 and
24 hours.
SDS-PAGE analysis and in-gel digestion for protein
identification
Total protein from BCM, PCM, and EpiLife growth
medium was quantified using a modified Lowry assay
following the manufacturer’s protocol (Thermo Scienti-
fic, Rockford, IL). Proteins were precipitated from 2 ml
of sample by adding 200 μl of a 1:4 solution of trichlor-
oacetic acid and acetone. The solution was incubated at
4°C for an hour. Samples were then centrifuged at
14,000 rpm for 15 minutes at 4°C. The supernatant was
decanted and the pellet was washed with 500 μlc o l d
acetone and centrifuged. After removing the superna-
tant, protein pellets were dried at room temperature
and re-suspended in 30 μl sample buffer (3.8 ml water,
1 ml 0.5 M Tris-HCl, pH 6.8, 0.8 ml glycerol, 1.6 ml
10% SDS, 0.4 ml 2-b-mercaptoethanol, 0.4 ml 0.05%
(W/V) bromophenol blue). Samples were incubated at
95°C for 5 minutes. Samples were run on a 12% acryla-
mide gel and stained with Coomassie brilliant blue R250
(BioRad, Hercules, CA). Excised gel slices were
destained using 50% acetonitrile in 50 mM ammonium
bicarbonate (pH 7.9) and vacuum dried. Samples were
rehydrated with 1.5 mg/ml dithiothreitol (DTT) in 25
mM ammonium bicarbonate (pH 8.5) at 56°C for 1 h,
Secor et al. BMC Microbiology 2011, 11:143
http://www.biomedcentral.com/1471-2180/11/143
Page 9 of 13subsequently alkylated with 10 mg/ml iodoacetamide
(IAA) in 25 mM ammonium bicarbonate (pH 8.5), and
stored in the dark at room temperature for 1 h. The
pieces were subsequently washed with 100 mM ammo-
nium bicarbonate (pH 8.5) for 15 min, washed twice
with 50% acetonitrile in 50 mM ammonium bicarbonate
(pH 8.5) for 15 min each, vacuum dried, and rehydrated
with 4 μl of proteomics grade modified trypsin (100 μg/
ml; Sigma, St. Louis, MO) in 25 mM ammonium bicar-
bonate (pH 8.5). The pieces were covered in a solution
of 10 mM ammonium bicarbonate with 10% acetonitrile
(pH 8.5) and incubated at 37°C for 16 h.
Liquid Chromatography-Tandem Mass Spectrometry
Liquid chromatography coupled to tandem mass spec-
trometry (LC/MS-MS) analysis was conducted at the
Mass Spectrometry Laboratory at Montana State Uni-
versity. Peptides were separated on a microfluidic Chip-
Cube interface and detected with an ESI-Trap XCT
Ultra instrument (Agilent, Santa Clara, CA). The MAS-
COT search engine was used to compare peptide masses
determined by MS to masses of sequences in the
NCBInr bacterial database. Acceptable protein identifi-
cations required expectation values of 0.01 for LC-MS/
MS.
Microarray
HFKs were grown to 90% confluence in six well plates.
Cells were then treated with 2 ml BCM, PCM, or EPI
for four hours. After treatment, the medium was
removed and RNA was isolated using an RNeasy minikit
(Qiagen, Valencia, CA) following the manufacturer’s
instructions for adherent cells. Extracted RNA was etha-
nol precipitated and resuspended in water as previously
described [71]. RNA concentrations and purity were
determined by measuring absorbencies at 260 nm and
280 nm on a GeneQuant spectrophotometer. RNA qual-
ity was also evaluated using the RNA 6000 NanoChip
assay on a 2100 Bioalyzer (Agilent Technologies, Palo
Alto, CA) in the Functional Genomics Core Facility at
Montana State University. RNA integrity number for all
samples used exceeded 9.5 on a scale to 10.
Total RNA (500 ng) was reverse transcribed, ampli-
fied and biotin-labeled via in vitro transcription using
the MessageAmp Premier kit (Applied Biosystems/
Ambion, Austin, TX). The resulting cRNA was frag-
mented and hybridized to Affymetrix GeneChip
Human Genome U133A 2.0 arrays (#900468, Affyme-
trix, Santa Clara, CA) at 45°C for 16 hours with con-
stant rotational mixing at 60 rpm. Washing and
staining of the arrays was performed using the Affyme-
trix GeneChip Fluidics Station 450. Arrays were
scanned using an Affymetrix GeneChip Scanner 7G
and GCOS software version 1.4.
M i c r o a r r a yd a t aw e r ea n a l y z e du s i n gF l e x A r r a yv e r -
sion 1.4. The Affymetrix CEL files were imported and
normalized using GC-RMA. Genes were filtered for
threshold signal intensities of at least 50 in one biologi-
cal replicate. Analysis of Variance (ANOVA) was per-
formed to identify statistically significant differences
among the three conditions. 910 genes were identified
(p-value < 0.01). The gene list was further trimmed to
identify genes with fold-change differences of at least 1.5
in any comparison, resulting in 575 genes. The log2
values were imported into Genesis [72] for visualization
and hierarchical clustering. Data were submitted to
Gene Expression Omnibus (NCBI) under accession
GSE24118. Subsequent functional enrichment analysis
was conducted using the database for annotation, visua-
lization and integrated discovery (DAVID) software [73].
The functional annotation clustering tool was used to
identify over-represented gene ontology terms (p < 0.05;
Benjamini correction for multiple testing) with the con-
servative high stringency option. Significantly upregu-
lated or downregulated genes with a fold change ± 1.5
(BCM relative to PCM) were submitted as separate lists.
Functional annotation clusters with an enrichment score
greater than 1.5 were considered significant.
Cytokine Detection by ELISA
Confluent HaCaT keratinocytes in 6-well plates were
cultured in the presence of bacterial conditioned med-
i u m( B C Mo rP C M )f o r4o r2 4h o u r s .C e l lc u l t u r e
supernatants were collected and analyzed by colori-
metric sandwich enzyme-linked immunoassays (ELISA)
for IL-1b, IL-6, TNF-a, CXCL-8, CXCL-1, and GM-CSF
(R&D Systems, Minneapolis, MN) following the manu-
facturer’s instructions. Cytokines in the supernatant
were detected as pg/ml. HKs remaining in the culture
wells were stained with propidium iodide and counted.
Cell counts per well and the measured percentage of
pro-apoptotic cells revealed by Terminal Deoxynucleoti-
dyl Transferase dUTP Nick End Labeling (TUNEL) were
used to normalize ELISA data to pg/100,000 adherent,
non-apoptotic cells.
Detection of MAPK Phosphorylation
HaCaT keratinocytes were grown to confluence in clear
bottom black walled 96-well plates. Keratinocytes were
treated with BCM or PCM for 4 or 24 hours. Total and
phosphorylated MAPKs (JNK, p38, and ERK) were
detected simultaneously using a cell-based ELISA (R&D
Systems, Minneapolis, MN) following the manufacturer’s
instructions.
Inhibition of MAPK
The p38 MAPK inhibitor, SB203580; the ERK inhibitor,
U0126; and the JNK inhibitor, SP600125 were prepared
Secor et al. BMC Microbiology 2011, 11:143
http://www.biomedcentral.com/1471-2180/11/143
Page 10 of 13as 10 mM DMSO stocks (Cayman Chemicals, Ann
Arbor, MI). Confluent HaCaT keratinocytes were pre-
treated with individual inhibitors or a combination of all
three inhibitors (10 μM each, 0.1% DMSO) in EPI
growth medium for one hour. Cells were then treated
with PCM or BCM supplemented with 10 μMi n h i b i t o r
(s) for four hours. Cell culture supernatants were col-
lected and analyzed by ELISA for cytokine production.
HaCaT keratinocytes treated with PCM or BCM supple-
mented with 0.1% DMSO were prepared as vehicle
controls.
Detection of apoptosis by TUNEL
TUNEL staining was used to investigate the induction of
apoptosis. HaCaT keratinocytes were grown to 90% con-
fluence on 18 mm
2 glass cover slips placed in six-well
plates. Keratinocytes were then exposed to 2 ml BCM,
PCM, or EPI. At 4 or 24 hours, apoptotic keratinocytes
were detected using the APO-BrdU TUNEL Assay Kit
(Invitrogen, Carlsbad, CA) following the manufacturer’s
staining protocol as previously described. Cells were
counter stained with propidium iodide. Coverslips were
imaged using a Nikon Eclipse E800 epifluorescent
microscope using a 10 × objective. For analysis, four
images of each condition were taken and numbers of
adherent cells staining positive for TUNEL and propi-
dium iodide were counted and the percentage of cells
staining positive for TUNEL were calculated.
Additional material
Additional file 1: Genes significantly regulated in BCM treated HKs.
Transcriptional profile (fold change ±1.5, pval < 0.01 BCM relative to
PCM) of HKs after four hours of exposure.
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